Generics player Neuraxpharm is continuing its push into Europe’s branded OTC market and taking its first steps into Austria with the acquisition of consumer healthcare specialist Easypharm for an undisclosed sum.
Through the deal, Neuraxpharm will gain a portfolio of OTC brands complementary to its existing offering of generic